… Rivaroxaban and apixaban are oral factor Xa inhibitors that were developed as alternatives
… the Rotochrom chromogenic anti-Xa assay (Diagnostica Stago, Parsippany, New Jersey, …

… factor Xa decoy protein that rapidly reverses the anticoagulant effects of direct oral factor Xa
inhibitors (FXai) like apixaban and … major bleeding or require emergent surgery. A recent …

… of Factor Xa inhibitors (FXaIs), currently four drugs: rivaroxaban (Xarelto), apixaban (Eliquis), …
In patients who had received apixaban, the median anti-factor Xa activity decreased from …

… andexanet alfa, especially in the absence of time from last dose of oral factor Xa inhibitor. …
concentrations before performing emergent surgical procedures [5]. Gilbert et al. utilized …

… Dabigatran is a new oral thrombin inhibitor and Rivaroxaban, Apixaban and Edoxaban
are oral factor Xa inhibitors. This review outlines why these new OACs were essential and …

… The options are limited for reversing the direct oral … agent for anti-factor Xa (anti-FXa)
inhibitors, coagulation factor Xa (… receiving apixaban, betrixaban, edoxaban, and rivaroxaban. …

… the degree of oral FXa inhibitor‐exposure in a timely and accurate manner, as the time
since last oral FXa administration is often unknown and apixaban‐ and rivaroxaban‐specific …

… Importantly, the anti-inflammatory effects of FXa inhibitors … , the anti-inflammatory effects
of rivaroxaban and apixaban … The anti-inflammatory effect of apixaban was also recently …

… presenting with serious bleeding while receiving apixaban or rivaroxaban. In this review, we
… Some cost reduction may be available through the manufacturer's New Technology Add-On …

… Oral Anticoagulants (DOACs) represent a group of new oral … The factor Xa inhibitors
apixaban and rivaroxaban have also … Direct factor Xa inhibitors do not influence TT, but have an …